Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease.

Selvaraj, Vijairam; Lal, Amos; Finn, Arkadiy; Tanzer, Joshua Ray; Baig, Muhammad; Jindal, Atin; Dapaah-Afriyie, Kwame; Bayliss, George

Selvaraj, Vijairam; Lal, Amos; Finn, Arkadiy; Tanzer, Joshua Ray; Baig, Muhammad; Jindal, Atin; Dapaah-Afriyie, Kwame; Bayliss, George.

Afiliação

Selvaraj V; Department of Medicine, Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI 02906, United States.
Lal A; Department of Medicine, Division of Pulmonary and Critical Care, Mayo Clinic, Rochester, MN 55905, United States. manavamos@gmail.com.
Finn A; Department of Medicine, Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI 02906, United States.
Tanzer JR; Department of Biostatistics Core, Lifespan Group, Providence, RI 02906, United States.
Baig M; Department of Medicine, Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI 02906, United States.
Jindal A; Department of Medicine, Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI 02906, United States.
Dapaah-Afriyie K; Department of Medicine, Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI 02906, United States.
Bayliss G; Department of Medicine, Rhode Island Hospital and Alpert Medical School, Bayliss, Division of Kidney and Hypertension, Brown University, Providence, RI 02906, United States.

World J Crit Care Med ; 11(1): 48-57, 2022 Jan 09.

Article em En | MEDLINE | ID: mdl-35433306

Palavras-chave

COVID-19; Dialysis; End stage renal disease; Hemodialysis; Kidney disease; Remdesivir

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: World J Crit Care Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google